Dr. Katherine Scilla, MD
Claim this profileUniversity of Maryland/Greenebaum Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
18 drugs studied
Area of expertise
1Lung Cancer
Stage II
Stage III
Stage I
2Non-Small Cell Lung Cancer
Stage II
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Katherine Scilla, MD is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Katherine Scilla, MD
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Katherine Scilla, MD has experience with
- Carboplatin
- Biospecimen Collection
- Pembrolizumab
- Repotrectinib (TPX-0005)
- Nivolumab
- Ipilimumab
Breakdown of trials Katherine Scilla, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Tumors
Malignant Pleural Mesothelioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katherine Scilla, MD specialize in?
Katherine Scilla, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Katherine Scilla, MD currently recruiting for clinical trials?
Yes, Katherine Scilla, MD is currently recruiting for 6 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Katherine Scilla, MD has studied deeply?
Yes, Katherine Scilla, MD has studied treatments such as Carboplatin, Biospecimen Collection, Pembrolizumab.
What is the best way to schedule an appointment with Katherine Scilla, MD?
Apply for one of the trials that Katherine Scilla, MD is conducting.
What is the office address of Katherine Scilla, MD?
The office of Katherine Scilla, MD is located at: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland 21201 United States. This is the address for their practice at the University of Maryland/Greenebaum Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.